| Andrea C Schneider, MS OTR | |
|
130 2nd St, Neenah, WI 54956-2883 | |
| (920) 729-3100 | |
| Not Available |
| Full Name | Andrea C Schneider |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 130 2nd St, Neenah, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407042443 | NPI | - | NPPES |
| 255X00000X | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 4373-026 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrea C Schneider, MS OTR Po Box 2759, Appleton, WI 54912-2759 Ph: (920) 830-5900 | Andrea C Schneider, MS OTR 130 2nd St, Neenah, WI 54956-2883 Ph: (920) 729-3100 |
News Archive
On Monday, President Donald Trump claimed that the World Health Organization (WHO) "admitted" he was correct that using lockdowns to control the spread of COVID-19 was more damaging than the illness.
A team of University of Houston pharmaceutical researchers is reporting a newly recognized process of drug metabolism in the intestines - followed by recycling through the liver - that could have important implications for developing treatments for intestinal diseases and for taking multiple medications at the same time.
A major study published in the New England Journal of Medicine, showed that men and women who ate an ounce of peanuts daily reduced their risk of death from all causes by up to 20%. Results also showed that peanut eaters were leaner. This gives people another great reason to get their daily handful of peanuts.
Cellectar, Inc., a privately held radiopharmaceutical company that designs and develops products to detect, treat and monitor human cancers, today announced that enrollment for its Phase I dosimetry trial for its lead drug candidate, (131)I-CLR1404 has been completed. Results of this trial will be used to set the starting dose in a follow-on Phase I dose escalation study planned for later this year. Institutions that participated in the trial include City of Hope, Duke University Medical Center, Georgetown University/Lombardi Cancer Center, and Johns Hopkins Hospital.
Inducing labor without a medical reason is associated with negative outcomes for the mother, including increased rates of cesarean delivery, greater blood loss and an extended length of stay in the hospital, and does not provide any benefit for the newborn.
› Verified 9 days ago
Sharon Rose Duchateau, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1305 W American Dr, Neenah, WI 54956 Phone: 920-725-9373 Fax: 920-720-7392 | |
Allison A Hoelzel, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-2616 Fax: 920-720-7350 | |
Allison Salm, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 125 Byrd Avenue, Neenah, WI 54956 Phone: 920-725-7869 | |
Teri Hable, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-3100 | |
William Rodney Degoey, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-2145 Fax: 920-729-2906 | |
Mary K Sahr, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 805 Hewitt St, Neenah, WI 54956 Phone: 920-277-2374 | |
Danielle Spranger, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-2616 |